| 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NM CNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
672 |
| 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
188 |
| Hypertensive Disorders of Pregnancy ISSHP Classification, Diagnosis, and Management Recommendations for International Practice |
153 |
| Measurement of Blood Pressure in Humans A Scientific Statement From the American Heart Association |
109 |
| Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association |
89 |
| Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults |
58 |
| Increased Preeclampsia Risk and Reduced Aortic Compliance With In Vitro Fertilization Cycles in the Absence of a Corpus Luteum |
46 |
| Nocturnal Hypertension New Technology and Evidence |
43 |
| Cardiovascular System in Preeclampsia and Beyond |
38 |
| Gut Microbiota Composition and Blood Pressure The CARDIA Study |
36 |
| A Universal Standard for the Validation of Blood Pressure Measuring Devices Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement |
35 |
| MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure |
34 |
| Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study |
34 |
| Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks |
32 |
| Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial) |
31 |
| Interaction Between Hypertension and Arterial Stiffness: An Expert Reappraisal |
31 |
| Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease |
29 |
| Nighttime Blood Pressure Measured by Home Blood Pressure Monitoring as an Independent Predictor of Cardiovascular Events in General Practice: The J-HOP Nocturnal Blood Pressure Study |
28 |
| Animal Models of Hypertension: A Scientific Statement From the American Heart Association |
27 |
| Physiological Diagnostic Criteria for Vascular Failure |
26 |
| Association Between Prepregnancy Cardiovascular Function and Subsequent Preeclampsia or Fetal Growth Restriction |
25 |
| Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term |
25 |
| Cellular and Genetic Causes of Idiopathic Hyperaldosteronism |
25 |
| Prevalence of Hypertension in Children: Applying the New American Academy of Pediatrics Clinical Practice Guideline |
24 |
| Prevalence of Apparent Treatment-Resistant Hypertension in the United States: Comparison of the 2008 and 2018 American Heart Association Scientific Statements on Resistant Hypertension |
24 |
| Consensus Document on Improving Hypertension Management in Asian Patients, Taking Into Account Asian Characteristics |
24 |
| Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism A Multicenter Study in Japan |
23 |
| Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment) |
23 |
| Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study |
23 |
| Prognostic Value of Masked Uncontrolled Hypertension: Systematic Review and Meta-Analysis |
22 |
| Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses |
21 |
| Endothelin: 30 Years From Discovery to Therapy |
21 |
| Concept of Extremes in Vascular Aging From Early Vascular Aging to Supernormal Vascular Aging |
21 |
| Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism |
21 |
| Role of Mitochondrial Dysfunction and Reactive Oxygen Species in Mediating Hypertension in the Reduced Uterine Perfusion Pressure Rat Model of Preeclampsia |
21 |
| Hypertension in Blacks: Individualized Therapy Based on Renin/Aldosterone Phenotyping |
21 |
| Association of Pulse Wave Velocity With Chronic Kidney Disease Progression and Mortality Findings From the CRIC Study (Chronic Renal Insufficiency Cohort) |
21 |
| Reduction in Regulatory T Cells in Early Pregnancy Causes Uterine Artery Dysfunction in Mice |
21 |
| ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic Neurons |
21 |
| Vascular Nox (NADPH Oxidase) Compartmentalization, Protein Hyperoxidation, and Endoplasmic Reticulum Stress Response in Hypertension |
20 |
| Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology |
20 |
| Pulse Wave Velocity Predicts the Progression of Blood Pressure and Development of Hypertension in Young Adults |
20 |
| Absent or Excessive Corpus Luteum Number Is Associated With Altered Maternal Vascular Health in Early Pregnancy |
20 |
| Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism |
20 |
| Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II-Induced Atrial Fibrillation in Mice |
19 |
| Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study |
19 |
| Myocardial Remodeling in Hypertension: Toward a New View of Hypertensive Heart Disease |
19 |
| Kidney Size, Renal Function, Ang (Angiotensin) Peptides, and Blood Pressure in Young Adults Born Preterm: The HAPI Study |
19 |
| 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status |
18 |
| Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
18 |
